Table 3.
Anthropometric and glyco-metabolic parameters at baseline and at 6 months after placebo
| Placebo group | ||
|---|---|---|
| Baseline | 6 months | |
| N | 86 | 83 |
| Sex (M/F) | 45/41 | 43/40 |
| Age (years) | 62.1±9.7 | 62.0±9.5 |
| Weight (kg) | 100.4±18.9 | 97.4±18.2 |
| WC (cm) | 107.5±10.1 | 106.7±9.8 |
| BMI (kg/m2) | 27.6±2.4 | 27.2±2.1 |
| FPG (mg/dL) | 148.7±37.8 | 142.4±35.2 |
| PPG (mg/dL) | 182.5±50.3 | 175.7±45.8 |
| HbA1c (%) | 7.2±1.5 | 7.0±1.3 |
| TC (mg/dL) | 184.2±22.5 | 180.1±21.9 |
| LDL-C (mg/dL) | 111.7±13.5 | 109.0±12.1 |
| HDL-C (mg/dL) | 40.2±5.9 | 39.6±5.7 |
| Tg (mg/dL) | 161.7±47.8 | 157.1±44.3 |
Notes: Data are expressed as mean ± standard deviation; p is not statistically significant.
Abbreviations: WC, waist circumference; BMI, body mass index; FPG, fasting plasma glucose; PPG, post-prandial plasma glucose; HbA1c, glycated hemoglobin; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; Tg, triglycerides.